Regeneron Pharmaceuticals Inc (REGN)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current REGN market cap is 114.64B. The company's latest EPS is USD 35.8654 and P/E is 29.16.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.16B | 3.36B | 3.43B | 3.15B | 3.55B |
| Operating Income | 1.02B | 1.11B | 972.9M | 751.4M | 1.07B |
| Net Income | 968.4M | 1.01B | 1.16B | 722M | 1.43B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 7.86B | 8.78B | 16.12B | 12.26B | 13.12B |
| Operating Income | 2.21B | 3.58B | 8.95B | 4.74B | 4.05B |
| Net Income | 2.12B | 3.51B | 8.08B | 4.34B | 3.95B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 30.66B | 32.16B | 33.08B | 34.37B | 36.09B |
| Total Liabilities | 6.64B | 7.26B | 7.11B | 7.38B | 7.88B |
| Total Equity | 24.02B | 24.9B | 25.97B | 26.99B | 28.21B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.81B | 17.16B | 25.43B | 29.21B | 33.08B |
| Total Liabilities | 3.72B | 6.14B | 6.67B | 6.55B | 7.11B |
| Total Equity | 11.09B | 11.03B | 18.77B | 22.66B | 25.97B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 2.39B | 3.5B | 4.59B | 1.51B | 1.87B |
| Investing | -2.62B | -3.12B | -3.19B | -1.69B | -2.24B |
| Financing | -936.7M | -1.34B | -1.79B | 47.1M | -431M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 2.43B | 2.62B | 7.08B | 5.01B | 4.59B |
| Investing | -2.03B | -70.6M | -5.38B | -3.78B | -3.19B |
| Financing | -252.1M | -1.97B | -1.01B | -1.01B | -1.79B |
| Market Cap | 114.64B |
| Price to Earnings Ratio | 29.16 |
| Price to Sales Ratio | 8.79 |
| Price to Cash Ratio | 42.24 |
| Price to Book Ratio | 4.44 |
| Dividend Yield | - |
| Shares Outstanding | 110.23M |
| Average Volume (1 week) | 669.05k |
| Average Volume (1 Month) | 501.45k |
| 52 Week Change | 26.36% |
| 52 Week High | 1,211.1999 |
| 52 Week Low | 769.19 |
| Spread (Intraday) | 16 (1.52%) |
| Company Name | Regeneron Pharmaceuticals Inc |
| Address |
28 liberty street new york, new york 10005 |
| Website | https://www.regeneron.com |
| Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
